The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism
NCT ID: NCT02042638
Last Updated: 2014-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16 participants
OBSERVATIONAL
2011-01-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSI
NCT02108223
The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients
NCT01980680
Low Dose Human Chorionic Gonadotropin: Influence on the Endometrium
NCT00976651
The Effects of Intrauterine Infusion of hCG at the Time of Embryo Transfer
NCT02668965
Endometrial Receptivity After GnRH Agonist Triggering
NCT01500863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
16 treatment naive Hypogonadotropic hypogonadism patients
Treatment naive 16 patients with idiopathic hypogonadotrophic hypogonadism
hCG 1500 IU three times a week
Pregnyl (hCG) ampule 1500 IU/three times a week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hCG 1500 IU three times a week
Pregnyl (hCG) ampule 1500 IU/three times a week
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
16 Years
45 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gulhane School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aydogan Aydogdu
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fahri Bayram, Proffesor
Role: STUDY_DIRECTOR
Erciyes University School of Medicine Depatment of Endocrinology and Metabolism Kayseri TURKEY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gulhane School of Medicine Dep. of Endocrinology and Metabolism
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
27122013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.